Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Universitätsklinik für Innere Medizin
Klinische Abteilung für Onkologie
SCI/PUBMED gelistet | alle Publikationstypen | Gesamt nach Jahr und Erstautor | MUG-Autor*innen |
** = Publikationen gelistet in SCI/SSCI/Pubmed
Originalarbeit (Zeitschrift)
** Brčić, I; Godschachner, TM; Igrec, J; Scheipl, S; Smolle, AM; Leithner, A; Szkandera, J; Liegl-Atzwanger, B
SS18-SSX and SSX c-terminus antibodies for identification of specific fusion oncoprotein in mesenchymal neoplasms.
Pathology. 2025;
Doi: 10.1016/j.pathol.2024.11.013
PubMed
FullText
FullText_MUG
** Chiang, AC; Olmedo, Garcia, ME; Carlisle, JW; Dowlati, A; Reguart, N; Felip, E; Jost, PJ; Steeghs, N; Stec, R; Gadgeel, SM; Loong, HH; Jiang, W; Hamidi, A; Parkes, A; Paz-Ares, L
Safety of tarlatamab with 6-8-h outpatient versus 48-h inpatient monitoring during cycle 1: DeLLphi-300 phase 1 substudy.
ESMO Open. 2025; 10(4):104538
Doi: 10.1016/j.esmoop.2025.104538
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** El, Kababji, S; Mitsakakis, N; Jonker, E; Beltran-Bless, AA; Pond, G; Vandermeer, L; Radhakrishnan, D; Mosquera, L; Paterson, A; Shepherd, L; Chen, B; Barlow, W; Gralow, J; Savard, MF; Fesl, C; Hlauschek, D; Balic, M; Rinnerthaler, G; Greil, R; Gnant, M; Clemons, M; El, Emam, K
Augmenting Insufficiently Accruing Oncology Clinical Trials Using Generative Models: Validation Study.
J Med Internet Res. 2025; 27:e66821
Doi: 10.2196/66821
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Englisch, C; Nopp, S; Moik, F; Starzer, AM; Quehenberger, P; Preusser, M; Berghoff, AS; Ay, C; Pabinger, I
The Vienna CATScore for predicting cancer-associated venous thromboembolism: an external validation across multiple time points.
ESMO Open. 2025; 10(2): 104130
Doi: 10.1016/j.esmoop.2024.104130
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Gampenrieder, SP; Vaisband, M; Rinnerthaler, G; Weiss, L; Jaud, B; Sprenger, M; Greil, R
A comparison of breast cancer incidence and cancer stages before and after the introduction of the Austrian national breast cancer screening program in the federal state of Salzburg : Real-world data from the Tumor Registry Salzburg.
Wien Klin Wochenschr. 2025;
Doi: 10.1007/s00508-025-02508-8
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Guillouet, C; Agostini, V; Baujat, G; Cocciadiferro, D; Pippucci, T; Lesieur-Sebellin, M; Georget, M; Schatz, U; Fauth, C; Louie, RJ; Rogers, C; Davis, JM; Konstantopoulou, V; Mayr, JA; Bouman, A; Wilke, M; VanNoy, GE; England, EM; Park, KL; Brown, K; Saenz, M; Novelli, A; Digilio, MC; Mastromoro, G; Rongioletti, MCA; Piacentini, G; Kaiyrzhanov, R; Guliyeva, S; Hasanova, L; Shears, D; Bhatnagar, I; Stals, K; Klaas, O; Horvath, J; Bouvagnet, P; Witmer, PD; MacCarrick, G; Cisarova, K; Good, JM; Gorokhova, S; Boute, O; Smol, T; Bruel, AL; Patat, O; Broadbent, JR; Tan, TY; Tan, NB; Lyonnet, S; Busa, T; Graziano, C; Amiel, J; Gordon, CT, , University, of, Washington, Center, for, Mendelian, Genomics
Bi-allelic MED16 variants cause a MEDopathy with intellectual disability, motor delay, and craniofacial, cardiac, and limb malformations.
Am J Hum Genet. 2025;
Doi: 10.1016/j.ajhg.2025.02.016
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Haidmayer, A; Adelsmayr, G; Spreizer, C; Klocker, EV; Quehenberger, F; Fuchsjaeger, M; Thiel, J; Hermann, J
Distribution of spinal damage in patients with axial spondyloarthritis as assessed by MRI: a prospective and blinded study.
Arthritis Res Ther. 2025; 27(1): 8
Doi: 10.1186/s13075-024-03465-9
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Hofer, S; Pauli, C; Bode, B; Bonvalot, S; Fotopoulou, C; Gelderblom, H; Haas, RL; Hardes, J; Hohenberger, P; Jakob, J; Kunz, WG; Leithner, A; Liegl-Atzwanger, B; Lindner, L; Miah, A; Reichardt, P; Rutkowski, P; Schaarschmidt, BM; Scheinemann, K; Szkandera, J; Wardelmann, E; Andreou, D; Rothermundt, C, , CCS2024, panellists
Conference on challenges in sarcoma (CCS) 2024: Expert opinions on non-evidence-based management aspects.
Eur J Cancer. 2025; 220:115368
Doi: 10.1016/j.ejca.2025.115368
Web of Science
PubMed
FullText
FullText_MUG
** Joch, S; Smolle, MA; Kashofer, K; Thüringer, A; Szkandera, J; Benesch, M; El-Heliebi, A; Liegl-Atzwanger, B; Leithner, A; Seidel, MG
New Insights from Long-Term Clinical Use of Circulating Tumor DNA-Based Minimal Residual Disease Monitoring in Translocation-Associated Sarcomas.
Oncol Res Treat. 2025; 48(4):186-196
Doi: 10.1159/000543223
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Moik, F; Absenger, G; Wurm, R; Hochmair, MJ; Ay, C
Prevention and Treatment of Venous Thromboembolism Associated with Amivantamab-Based Therapies in Patients with Lung Cancer-Provisional Clinical Opinion Based on Existing Clinical Practice Guidelines.
Cancers (Basel). 2025; 17(2):
Doi: 10.3390/cancers17020259
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Moik, F; Terbuch, A; Sprakel, A; Pichler, G; Barth, DA; Pichler, R; Rainer, P; Silbernagel, G; Mannweiler, S; Jost, PJ; Ahyai, SA; Bauernhofer, T; Hutterer, GC; Pichler, M
Arterial thromboembolic events in testicular cancer patients: short- and long-term incidence, risk factors, and impact on mortality.
J Thromb Haemost. 2025;
Doi: 10.1016/j.jtha.2025.01.022
PubMed
FullText
FullText_MUG
** Niedersuess-Beke, D; Mayrhofer, K; Krauter, J; Schnabel, S; Gampenrieder, SP; Miechowiecki, J; Kiesl, D; Luger, F; Pfuner, J; Wiesinger, C; Vallet, S; Andalibi, H; Vais, D; Banner, A; Stoiber, F; Spielgelberg, J; Barth, D; Bauernhofer, T; Aufderklamm, S; Weibrecht, S; Mühlmann, J; Mayer, M; Hilbe, W; Boulmé, F; Klinglmair, G; Heintel, D; Shariat, SF; Pichler, M; Pichler, R
Real-world Evidence for Enfortumab Vedotin in Patients with Metastatic Urothelial Cancer: An Austrian Multicentre Study.
Clin Genitourin Cancer. 2025; 23(1):102278
Doi: 10.1016/j.clgc.2024.102278
Web of Science
PubMed
FullText
FullText_MUG
** Riedl, JM; Fece, de, la, Cruz, F; Lin, JJ; Parseghian, C; Kim, JE; Matsubara, H; Barnes, H; Caughey, B; Norden, BL; Morales, A; Kushner, EW; Ehnstrom, S; Nakamura, H; Patel, PS; Ellis, H; Pappas, L; Vakaris, A; Gainor, JF; Kopetz, S; Klempner, SJ; Parikh, AR; Hata, AN; Heist, RS; Corcoran, RB
Genomic landscape of clinically acquired resistance alterations in patients treated with KRASG12C inhibitors.
Ann Oncol. 2025;
Doi: 10.1016/j.annonc.2025.01.020
[OPEN ACCESS]
PubMed
FullText
FullText_MUG
** Rinnerthaler, G; Egle, D; Bartsch, R; Schmitt, CA; Petzer, A; Balic, M; Petru, E; Denison, U; Singer, CF; Bjelic-Radisic, V; Gampenrieder, SP; Knauer, M; Sotlar, K; Brunner, C; Posch, F; Hlauschek, D; Sölkner, L; Bago-Horvath, Z; Filipits, M; Gili, M; Ritter, M; Wieser, V; Albertini, C; Zaborsky, N; Weiss, L; Marhold, M; Schneeweiss, B; Pusch, R; Gnant, M; Greil, R
Neoadjuvant atezolizumab in combination with dual HER2 blockade plus epirubicin in women with early HER2-positive breast cancer: the randomized phase 2 ABCSG-52/ATHENE trial.
Nat Cancer. 2025;
Doi: 10.1038/s43018-024-00890-2
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Roohani, S; Handtke, J; Hummedah, K; Albertsmeier, M; Andreou, D; Apostolidis, L; Augustin, M; Bauer, S; Billner, M; Bösch, F; Deinzer, CKW; Deventer, N; Duprée, A; Eckert, F; Engel, L; Fechner, K; Fritzsche, H; Gaidzik, V; Ghani, S; Grützmann, R; Guder, WK; Hamacher, R; Hecker, JS; Hendricks, A; Hillmann, A; Houben, P; Hübner, G; Ivanyi, P; Jentsch, C; Jordan, M; Kappl, P; Kaths, M; Kessler, T; Kirchberg, J; Knebel, C; Krempien, R; Lehner, B; Lenze, U; Lindner, LH; Lörsch, AM; Maguire, N; Müller, S; Piso, P; Potkrajcic, V; Reichardt, P; Richter, S; Schewe, S; Schiffmann, LM; Scholten, F; Striefler, JK; Schwarzbach, M; Seidensaal, K; Semrau, S; Szkandera, J; Szuszies, CJ; Timmermann, B; Tuscherer, A; Wiegering, A; Winkelmann, MT; Kaul, D; Jakob, J
The sarcoma ring trial: a case-based analysis of inter-center agreement across 21 German-speaking sarcoma centers.
J Cancer Res Clin Oncol. 2025; 151(1): 30
Doi: 10.1007/s00432-024-06063-z
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Schlemmer, AJ; Gorkiewicz, G; Uggowitzer, MM; Salamon, S; Jost, P; Talakic, E
18F-FDG PET/CT in NUT Carcinoma of the Thorax.
Clin Nucl Med. 2025;
Doi: 10.1097/RLU.0000000000005872
PubMed
FullText
FullText_MUG
** Singer, CF; Jahn, SW; Hlauschek, D; Heber, UM; Mang-Manger, C; Egle, D; Balic, M; Pichler, A; Pfeiler, G; Kacerovsky-Strobl, S; Suppan, C; Ritter, M; Petru, E; Greil, R; Bago-Horvath, Z; Deutschmann, C; Steger, GG; Seifert, M; Fitzal, F; Bartsch, R; Santhanagopal, A; Machacek-Link, J; Sellami, D; Schwarz, M; Fesl, C; Sölkner, L; Esker, S; Filipits, M; Gnant, M, , Austrian, Breast, and, Colorectal, Cancer, Study, Group
HER2 and HER3 expression during neoadjuvant treatment of HER2-negative early breast cancer: potential for biomarker-driven sequencing of T-DXd and HER3-DXd.
Cancer Commun (Lond). 2025;
Doi: 10.1002/cac2.12657
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Theiler-Schwetz, V; Trummer, C; Schmitt, L; Terbuch, A; Obermayer-Pietsch, B; Richtig, E; Pilz, S
High-dose glucocorticoid treatment vs. glucocorticoid replacement in immune checkpoint inhibitor associated hypophysitis (CORTICI): an open, randomised controlled trial.
Ann Med. 2025; 57(1): 2453829
Doi: 10.1080/07853890.2025.2453829
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Unseld, M; Kühberger, S; Graf, R; Beichler, C; Braun, M; Dandachi, N; Heitzer, E; Prager, GW
Circulating tumor DNA (ctDNA) trajectories predict survival in trifluridine/tipiracil-treated metastatic colorectal cancer patients.
Mol Oncol. 2025;
Doi: 10.1002/1878-0261.13755
Web of Science
PubMed
FullText
FullText_MUG
** Verso, M; Moik, F; Graziani, M; Cohen, AT
Response to Comment on: "Targeted anti-cancer agents and risk of venous thromboembolism".
Haematologica. 2025;
Doi: 10.3324/haematol.2025.287998
PubMed
FullText
FullText_MUG
** Wimmer, K; Hlauschek, D; Balic, M; Pfeiler, G; Greil, R; Singer, CF; Halper, S; Steger, G; Suppan, C; Gampenrieder, SP; Helfgott, R; Egle, D; Filipits, M; Jakesz, R; Sölkner, L; Fesl, C; Gnant, M; Fitzal, F, , Austrian, Breast, &, Colorectal, Cancer, Study, Group
Validation of the CTS5 in four prospective, multicenter, randomized ABCSG trials.
Breast. 2025; 80:104415
Doi: 10.1016/j.breast.2025.104415
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Kurzbericht/Letter
** Smolle, MA; Wenzl, FA; Szkandera, J; Scheipl, S; Liegl-Atzwanger, B; Igrec, J; Leithner, A
Incidence of and survival with bone and soft tissue sarcoma: A nation-wide study over four decades.
Cancer Commun (Lond). 2025; 45(4):397-400
Doi: 10.1002/cac2.12653
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Übersichtsarbeit
** Abdel, Hamid, M; Pammer, LM; Oberparleiter, S; Günther, M; Amann, A; Gruber, RA; Mair, A; Nocera, FI; Ormanns, S; Zimmer, K; Gerner, RR; Kocher, F; Vorbach, SM; Wolf, D; Riedl, JM; Huemer, F; Seeber, A
Multidimensional differences of right- and left-sided colorectal cancer and their impact on targeted therapies.
NPJ Precis Oncol. 2025; 9(1):116
Doi: 10.1038/s41698-025-00892-y
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Klocker, EV; Egle, D; Bartsch, R; Rinnerthaler, G; Gnant, M
Efficacy and Safety of CDK4/6 Inhibitors: A Focus on HR+/HER2- Early Breast Cancer.
Drugs. 2025;
Doi: 10.1007/s40265-024-02144-y
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Rieke, DT; Bitzer, M; Bleckmann, A; Desuki, A; Ernst, T; Esposito, I; Gerger, A; Glimm, H; Horak, P; Hübschmann, D; Illert, AL; Kunzmann, V; Loges, S; Pretzell, I; Schmitz, K; Seeber, A; Söhlke, B; Wicki, A; Wolf, J; Maschmeyer, G
Precision oncology - Guideline of the Austrian, German and Swiss Societies for hematology and medical oncology.
Eur J Cancer. 2025; 220:115331
Doi: 10.1016/j.ejca.2025.115331
Web of Science
PubMed
FullText
FullText_MUG
Korrektur
** Roohani, S; Handtke, J; Hummedah, K; Albertsmeier, M; Andreou, D; Apostolidis, L; Augustin, M; Bauer, S; Billner, M; Bösch, F; Deinzer, CKW; Deventer, N; Duprée, A; Eckert, F; Engel, L; Fechner, K; Fritzsche, H; Gaidzik, V; Ghani, S; Grützmann, R; Guder, WK; Hamacher, R; Hecker, JS; Hendricks, A; Hillmann, A; Houben, P; Hübner, G; Ivanyi, P; Jentsch, C; Jordan, M; Kappl, P; Kaths, M; Kessler, T; Kirchberg, J; Knebel, C; Krempien, R; Lehner, B; Lenze, U; Lindner, LH; Lörsch, AM; Maguire, N; Müller, S; Piso, P; Potkrajcic, V; Reichardt, P; Richter, S; Schewe, S; Schiffmann, LM; Scholten, F; Striefler, JK; Schwarzbach, M; Seidensaal, K; Semrau, S; Szkandera, J; Szuszies, CJ; Timmermann, B; Tuchscherer, A; Wiegering, A; Winkelmann, MT; Kaul, D; Jakob, J
Correction: The sarcoma ring trial: a case-based analysis of inter-center agreement across 21 German-speaking sarcoma centers.
J Cancer Res Clin Oncol. 2025; 151(4):149
Doi: 10.1007/s00432-025-06193-y
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Abstract (Zeitschrift)
** Breitenstein, U; Wrobel, D; Guth, D; Zaiss, M; Terhaag, J; Zahn, MO; Perlova-Griff, L; Distelrath, A; Wuerstlein, R; Apel, K; Deuerling, N; Vannier, C; Bartsch, R; Jackisch, C; Mueller, V; Schmidt, M; Balic, M; Rinnerthaler, G; Lueftner, D; Zaman, K; Schwitter, M; Harbeck, N
Extended adjuvant (adj) neratinib in HER2+/HR+ early breast cancer (eBC) in clinical routine - interim analysis of the multinational, prospective, non-interventional study (NIS) ELEANOR (n=300)
BREAST. 2025; 80: 103911
Doi: 10.1016/j.breast.2025.103911
Web of Science
FullText
FullText_MUG
** Hechenberger, S; Helmlinger, B; Jordan, S; Wurth, S; Heschl, B; Damulina, A; Eppinger, S; Khalil, M; Enzinger, C; Pinter, D
Reliable Change Index for the self-administered, IPad-based processing speed test - the PST
MULT SCLER J. 2025; 31(1_SUPPL):
Web of Science
** Helmlinger, B; Hechenberger, S; Hutter, J; Jordan, S; Wurth, S; Damulina, A; Heschl, B; Khalil, M; Enzinger, C; Pinter, D
Distinct contribution of motor function and psychological factors on motor fatigue
MULT SCLER J. 2025; 31(1_SUPPL): P28
Web of Science
** Wimmer, K; Hlauschek, D; Balic, M; Pfeiler, G; Greil, R; Singer, CF; Halper, S; Steger, G; Suppan, C; Gampenrieder, SP; Helfgott, R; Egle, D; Filipits, M; Jakesz, R; Sölkner, L; Fesl, C; Gnant, M; Fitzal, F
Validation of the CTS5 in four prospective, multicenter, randomized ABCSG trials
BREAST. 2025; 80: 103905
Doi: 10.1016/j.breast.2025.103905
Web of Science
FullText
FullText_MUG